Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06223828
PHASE2/PHASE3
Azithromycin for Critical Asthma - Pediatrics
Sponsor: Johns Hopkins All Children's Hospital
View on ClinicalTrials.gov
Summary
The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.
Official title: Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking
Key Details
Gender
All
Age Range
3 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-04-02
Completion Date
2026-12-31
Last Updated
2025-12-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
Azithromycin
10mg/kg/dose (max dose 500mg) once daily for 3 days
Locations (1)
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, United States